| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/31/2001 | US6267994 Use of extract of cimicifuga racemosa |
| 07/31/2001 | CA2282890C Therapeutic heterocyclic compounds |
| 07/26/2001 | WO2000015178A3 Computer implemented pharmacokinetics method and program |
| 07/26/2001 | US20010009909 Of fatty acid ester, such as sorbitan monolaurate or monostearate, in aqueous medium containing an anionic detergent surfactant; reducing eye-irritant and improving thickening for better distribution and emulsification; shampoo |
| 07/26/2001 | US20010009903 Roasting process using far infrared radiation, microorganism fermentation to produce peroxide lipid thereby improving antitumor activity |
| 07/26/2001 | DE10100779A1 Formulierung Formulation |
| 07/26/2001 | CA2332214A1 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 07/25/2001 | EP1117652A1 Tan-1057 derivatives |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117442A1 Dry powder active agent pulmonary delivery |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | CN1305483A Polymorphic clopidogrel hydrogenesulphate form |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305378A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal fragility |
| 07/25/2001 | CN1305373A Therapeutic combinations comprising selective estrofen receptor modulator and parathyroid hormone |
| 07/25/2001 | CN1305369A Pharmaceutical aerosol formulation |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1068880C N-substituted piperidingl bicyclic benzoate derivatives |
| 07/24/2001 | US6265397 Amidino derivatives and their use as thrombin inhibitors |
| 07/24/2001 | US6264931 Reaction product of alkanolamine, fatty acid or fatty ester and alkylation agent; mixture with anionic surfactant |
| 07/24/2001 | US6264917 Targeted ultrasound contrast agents |
| 07/24/2001 | CA2218503C Arylsulfonyl hydroxamic acid derivatives |
| 07/24/2001 | CA2201959C Photostable sunscreen composition comprising a dibenzoylmethane derivative and a polysaccharide alkylether and its uses |
| 07/19/2001 | WO2001051078A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| 07/19/2001 | WO2001051059A1 Processes for preparing clarithromycin polymorphs |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001005353A3 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 07/19/2001 | WO2000071104A3 Use of bisphosphonic acids for treating angiogenesis |
| 07/19/2001 | US20010008639 Reducing dosage; analgesics |
| 07/19/2001 | US20010008031 Oxidizing mixture containing ascorbic acid, metal compound and oxidizer |
| 07/19/2001 | DE10101543A1 Enhancing the antitumor activity of an amygdalin-containing material, especially loquat kernels, comprises roasting the material with far infrared radiation and fermenting it with microorganisms |
| 07/19/2001 | CA2397092A1 Processes for preparing clarithromycin polymorphs |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2396157A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/18/2001 | EP1115388A1 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants |
| 07/18/2001 | EP1115387A2 Anti-microbial-adhesion fraction derived from vaccinium |
| 07/18/2001 | EP1115382A2 Immunogenic liposome compositions |
| 07/18/2001 | EP1115373A1 Oral composition with an improved teeth whitening effect |
| 07/18/2001 | EP1115371A1 Oral care compositions |
| 07/18/2001 | EP0667787B1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 07/18/2001 | CN1304307A 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists |
| 07/18/2001 | CN1303664A Pigment compositions for dyeing hair |
| 07/17/2001 | US6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
| 07/17/2001 | US6262052 Amino acid ester containing azole antifungals |
| 07/17/2001 | US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran |
| 07/17/2001 | US6261599 Sustained release |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | CA2331167A1 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049263A1 Inhalation particles |
| 07/12/2001 | WO2000002521A3 Symptomatic relief of allergic reactions |
| 07/12/2001 | CA2330465A1 Process for increasing egg production and strenghtening poultry egg shell |
| 07/11/2001 | EP1114817A1 Substituted benzylamino piperidine compounds |
| 07/11/2001 | EP1114032A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1113824A2 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 07/11/2001 | EP1113811A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 07/11/2001 | EP0593516B1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 07/11/2001 | CN1303379A 2-Aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303378A 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for treatment of HIV related diseases |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303364A Aminocyclohexyl ether compounds and uses thereof |
| 07/11/2001 | CN1303297A Treatment of arthritis and other similar conditions |
| 07/11/2001 | CN1303296A Process of powder for bath from natural plants |
| 07/11/2001 | CN1303279A Topical transdermal treatments |
| 07/11/2001 | CN1302800A Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 07/11/2001 | CN1068333C Sterol derivatives used as regulation of meiosis |
| 07/10/2001 | WO2001051056A1 Fulvestrant formulation |
| 07/10/2001 | US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds. |
| 07/10/2001 | US6258809 6-aryloxy and arylthiopurines |
| 07/10/2001 | US6258804 Triazepinones, process for their preparation and their therapeutic application |
| 07/10/2001 | US6258340 Using water-soluble dyes and their biomolecule adducts each having specific photophysical and pharmochemical properties |
| 07/10/2001 | CA2139653C Optically pure salts of pyridinylmethyl sulfinyl-ih- benzimidazole compounds |
| 07/05/2001 | WO2001047926A1 Compounds and methods for the treatment of pain |
| 07/05/2001 | WO2001047893A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/05/2001 | WO2001047495A1 Pharmaceutical compositions providing enhanced drug concentrations |
| 07/05/2001 | WO2001047477A2 Agent for dyeing keratin containing fibers |
| 07/05/2001 | WO2000078332A3 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/05/2001 | US20010006981 Compositions containing an antifungal and a cationic agent |
| 07/05/2001 | US20010006976 Efficent, notoxic process of making new key intermediate quaternary ammonium salts and 2-oxazolylalkyl sulfide derivatives and avoids the reaction of a-haloketones with an azide followed by reducing the resulting a-aminoketone |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/05/2001 | US20010006686 Extract; antiinflammatory agent for treatment of cyclooxygenase-2 (COX-2) conditions such as arthritis, pain from cancer; selective inhibition of COX-2 over COX-1 |
| 07/05/2001 | CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/04/2001 | EP1112272A1 Muscarinic agonists and antagonists |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112061A1 Drug preparations for treating sexual dysfunction |
| 07/04/2001 | CN1302301A Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidine sas inhibitors of cellular proliferation |
| 07/04/2001 | CN1302211A Improvements in/or relating to diagnostic/therapeutic agent |
| 07/04/2001 | CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease |
| 07/04/2001 | CN1302204A Novel fatty analogues for treatment of diabetes |
| 07/04/2001 | CN1067989C New compound with analgesic and local anaesthetic effect |
| 07/03/2001 | US6255334 5HT 1 receptor agonists and metoclopramide for the treatment of migraine |
| 07/03/2001 | US6255307 Pyrazine compounds |
| 07/03/2001 | US6254896 Apparatus and process for in situ manufacture of essence from living, uncut plants |
| 07/03/2001 | US6254887 Controlled release tramadol |
| 07/03/2001 | US6254882 Ion exchanging of drug delivery |
| 07/03/2001 | US6254857 Effervescent whitening dentifrice having oxygen-derived sensory signal |